Helus Pharma Inc. Share Price
NASDAQ: HELPHelus Pharma Inc. Stock Performance
Helus Pharma Inc. Share Price Today
As of 30 October 2026, Helus Pharma Inc.'s share price is $10.70. The stock opened at $10.97, compared to its previous close of $10.89. During today's trading session, Helus Pharma Inc.'s share price traded between $10.52 and $11.16, with an average price of $10.84. Over the past 52 weeks, the stock has recorded a high of $14.88 and a low of $3.78. In terms of performance, Helus Pharma Inc.'s share price has risen by 101.89% over the last six months and is up 61.88% on a year-on-year basis.
Helus Pharma Inc. Share Price Chart
About Helus Pharma Inc.
Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.
Helus Pharma Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $12.38 | $10.70 | -12.94% |
Sep 2026 | $11.79 | $12.29 | -7.11% |
Aug 2026 | $7.88 | $13.22 | +69.33% |
Jul 2026 | $6.49 | $7.81 | +18.33% |
Jun 2026 | $4.42 | $6.60 | +45.21% |
May 2026 | $5.26 | $4.54 | -14.25% |
Apr 2026 | $4.94 | $5.30 | +10.65% |
Mar 2026 | $7.13 | $4.79 | -34.79% |
Feb 2026 | $6.51 | $7.34 | +11.12% |
Jan 2026 | $8.60 | $6.61 | N/A |